Laver, Kate E. https://orcid.org/0000-0003-0259-2209
Crotty, Maria
Low, Lee-Fay
Clemson, Lindy
Whitehead, Craig
McLoughlin, James
Swaffer, Kate
Cations, Monica
Funding for this research was provided by:
Flinders University
Article History
Received: 26 July 2020
Accepted: 30 November 2020
First Online: 9 December 2020
Ethics approval and consent to participate
: This study was approved by the Southern Adelaide Clinical Human Research Ethics Committee (HREC/16/SAC/454). Capacity of the person to provide informed consent was determined through conversation and the person’s ability to answer questions about the purpose and procedures of the study after the study was explained. Informed consent was obtained from all participants. When interviews were conducted by telephone we obtained verbal consent as described in our ethics application.
: Participants in the interviews provided consent for their data to be published in journal articles in a manner that did not identify them.
: MCa has been employed in the past 5 years to assist with data collection for Alzheimer’s disease drug trials funded by Janssen and Merck. MCr receives funding from Novartis for trials of hip fracture involving treatments for sarcopenia. All other authors declare no competing interests.